Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Rev Soc Bras Med Trop ; 56: e00152023, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37493729

RESUMO

BACKGROUND: The number of tuberculosis (TB) cases in prisons is higher than that in the general population and has been reported as the most common cause of death in prisons. This study evaluated the delay in the diagnosis and treatment of TB in Brazilian prisons. METHODS: A retrospective cohort study was conducted between 2007 and 2015 using data from the five largest male prisons in Mato Grosso do Sul, Brazil. TB case data was collected from the National Database of Notifiable Diseases (SINAN), GAL-LACEN, and prison medical records. The following variables were recorded: prison, year of diagnosis, age, race, education, HIV status, smoking status, comorbidities, number of symptoms, percentage of cures, delay in diagnosis, patient delay, provider delay, laboratory delay, and delay in treatment. Descriptive statistics were used for the variables of interest. RESULTS: A total of 362 pulmonary TB cases were identified. The average time between the first symptom and reporting of data was 94 days. The mean time between symptom onset and laboratory diagnosis was 91 days. The average time from symptom onset to first consultation was 80 days. The time between diagnosis and treatment initiation was 5 days. CONCLUSIONS: Delays were significant between reporting of the first symptoms and diagnosis and significantly smaller from the time between notification and start of treatment. Control strategies should be implemented to diagnose cases through active screening, to avoid delays in diagnosis and treatment, and to reduce TB transmission.


Assuntos
Tuberculose Pulmonar , Tuberculose , Humanos , Masculino , Prisões , Brasil/epidemiologia , Estudos Retrospectivos , Tuberculose/diagnóstico , Tuberculose/tratamento farmacológico , Tuberculose/epidemiologia , Tuberculose Pulmonar/diagnóstico , Tuberculose Pulmonar/tratamento farmacológico , Tuberculose Pulmonar/epidemiologia
2.
Lancet Reg Health Am ; 17: 100388, 2023 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-36776567

RESUMO

Background: The World Health Organization (WHO) recommends systematic tuberculosis (TB) screening in prisons. Evidence is lacking for accurate and scalable screening approaches in this setting. We aimed to assess the accuracy of artificial intelligence-based chest x-ray interpretation algorithms for TB screening in prisons. Methods: We performed prospective TB screening in three male prisons in Brazil from October 2017 to December 2019. We administered a standardized questionnaire, performed a chest x-ray in a mobile unit, and collected sputum for confirmatory testing using Xpert MTB/RIF and culture. We evaluated x-ray images using three algorithms (CAD4TB version 6, Lunit version 3.1.0.0 and qXR version 3) and compared their accuracy. We utilized multivariable logistic regression to assess the effect of demographic and clinical characteristics on algorithm accuracy. Finally, we investigated the relationship between abnormality scores and Xpert semi-quantitative results. Findings: Among 2075 incarcerated individuals, 259 (12.5%) had confirmed TB. All three algorithms performed similarly overall with area under the receiver operating characteristic curve (AUC) of 0.88-0.91. At 90% sensitivity, only LunitTB and qXR met the WHO Target Product Profile requirements for a triage test, with specificity of 84% and 74%, respectively. All algorithms had variable performance by age, prior TB, smoking, and presence of TB symptoms. LunitTB was the most robust to this heterogeneity but nonetheless failed to meet the TPP for individuals with previous TB. Abnormality scores of all three algorithms were significantly correlated with sputum bacillary load. Interpretation: Automated x-ray interpretation algorithms can be an effective triage tool for TB screening in prisons. However, their specificity is insufficient in individuals with previous TB. Funding: This study was supported by the US National Institutes of Health (grant numbers R01 AI130058 and R01 AI149620) and the State Secretary of Health of Mato Grosso do Sul.

3.
Rev. Soc. Bras. Med. Trop ; 56: e0015, 2023. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1449343

RESUMO

ABSTRACT Background: The number of tuberculosis (TB) cases in prisons is higher than that in the general population and has been reported as the most common cause of death in prisons. This study evaluated the delay in the diagnosis and treatment of TB in Brazilian prisons. Methods: A retrospective cohort study was conducted between 2007 and 2015 using data from the five largest male prisons in Mato Grosso do Sul, Brazil. TB case data was collected from the National Database of Notifiable Diseases (SINAN), GAL-LACEN, and prison medical records. The following variables were recorded: prison, year of diagnosis, age, race, education, HIV status, smoking status, comorbidities, number of symptoms, percentage of cures, delay in diagnosis, patient delay, provider delay, laboratory delay, and delay in treatment. Descriptive statistics were used for the variables of interest. Results: A total of 362 pulmonary TB cases were identified. The average time between the first symptom and reporting of data was 94 days. The mean time between symptom onset and laboratory diagnosis was 91 days. The average time from symptom onset to first consultation was 80 days. The time between diagnosis and treatment initiation was 5 days. Conclusions: Delays were significant between reporting of the first symptoms and diagnosis and significantly smaller from the time between notification and start of treatment. Control strategies should be implemented to diagnose cases through active screening, to avoid delays in diagnosis and treatment, and to reduce TB transmission.

4.
PLoS Med ; 18(9): e1003789, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-34534214

RESUMO

BACKGROUND: Mortality during and after incarceration is poorly understood in low- and middle-income countries (LMICs). The need to address this knowledge gap is especially urgent in South America, which has the fastest growing prison population in the world. In Brazil, insufficient data have precluded our understanding of all-cause and cause-specific mortality during and after incarceration. METHODS AND FINDINGS: We linked incarceration and mortality databases for the Brazilian state of Mato Grosso do Sul to obtain a retrospective cohort of 114,751 individuals with recent incarceration. Between January 1, 2009 and December 31, 2018, we identified 3,127 deaths of individuals with recent incarceration (705 in detention and 2,422 following release). We analyzed age-standardized, all-cause, and cause-specific mortality rates among individuals detained in different facility types and following release, compared to non-incarcerated residents. We additionally modeled mortality rates over time during and after incarceration for all causes of death, violence, or suicide. Deaths in custody were 2.2 times the number reported by the national prison administration (n = 317). Incarcerated men and boys experienced elevated mortality, compared with the non-incarcerated population, due to increased risk of death from violence, suicide, and communicable diseases, with the highest standardized incidence rate ratio (IRR) in semi-open prisons (2.4; 95% confidence interval [CI]: 2.0 to 2.8), police stations (3.1; 95% CI: 2.5 to 3.9), and youth detention (8.1; 95% CI: 5.9 to 10.8). Incarcerated women experienced increased mortality from suicide (IRR = 6.0, 95% CI: 1.2 to 17.7) and communicable diseases (IRR = 2.5, 95% CI: 1.1 to 5.0). Following release from prison, mortality was markedly elevated for men (IRR = 3.0; 95% CI: 2.8 to 3.1) and women (IRR = 2.4; 95% CI: 2.1 to 2.9). The risk of violent death and suicide was highest immediately post-release and declined over time; however, all-cause mortality remained elevated 8 years post-release. The limitations of this study include inability to establish causality, uncertain reliability of data during incarceration, and underestimation of mortality rates due to imperfect database linkage. CONCLUSIONS: Incarcerated individuals in Brazil experienced increased mortality from violence, suicide, and communicable diseases. Mortality was heightened following release for all leading causes of death, with particularly high risk of early violent death and elevated all-cause mortality up to 8 years post-release. These disparities may have been underrecognized in Brazil due to underreporting and insufficient data.


Assuntos
Doenças Transmissíveis/mortalidade , Homicídio , Prisões Locais , Prisioneiros , Suicídio Consumado , Violência , Adolescente , Adulto , Brasil/epidemiologia , Causas de Morte , Doenças Transmissíveis/diagnóstico , Bases de Dados Factuais , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Fatores de Tempo , Adulto Jovem
5.
Clin Infect Dis ; 72(5): 771-777, 2021 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-32064514

RESUMO

BACKGROUND: Tuberculosis (TB) is a major cause of morbidity and mortality among incarcerated populations globally. We performed mass TB screening in 3 prisons and assessed yield, efficiency, and costs associated with various screening algorithms. METHODS: Between 2017 and 2018, inmates from 3 prisons in Brazil were screened for TB by symptom assessment, chest radiography, sputum testing by Xpert MTB/RIF fourth-generation assay, and culture. Chest radiographs were scored by an automated interpretation algorithm (Computer-Aided Detection for Tuberculosis [CAD4TB]) that was locally calibrated to establish a positivity threshold. Four diagnostic algorithms were evaluated. We assessed the yield (percentage of total cases found) and efficiency (prevalence among those screened) for each algorithm. We performed unit costing to estimate the costs of each screening or diagnostic test and calculated the cost per case detected for each algorithm. RESULTS: We screened 5387 prisoners, of whom 214 (3.9%) were diagnosed with TB. Compared to other screening strategies initiated with chest radiography or symptoms, the trial of all participants with a single Xpert MTB/RIF sputum test detected 74% of all TB cases at a cost of US$249 per case diagnosed. Performing Xpert MTB/RIF screening tests only on those with symptoms had a similar cost per case diagnosed (US$255) but missed 35% more cases (73 vs 54) as screening all inmates. CONCLUSIONS: In this prospective study in 3 prisons in a high TB burden country, we found that testing all inmates with sputum Xpert MTB/RIF was a sensitive approach, while remaining cost-efficient. These results support use of Xpert MTB/RIF for mass screening in TB-endemic prisons.


Assuntos
Infecções por HIV , Mycobacterium tuberculosis , Tuberculose , Algoritmos , Brasil/epidemiologia , Humanos , Programas de Rastreamento , Prisões , Estudos Prospectivos , Sensibilidade e Especificidade , Escarro , Tuberculose/diagnóstico , Tuberculose/epidemiologia
6.
Artigo em Inglês | MEDLINE | ID: mdl-33174978

RESUMO

Syphilis is a public health problem, especially in pregnant women, due to the risk of transmission to the fetus and the involvement of the central nervous system, causing neurosyphilis. A case-control study was carried out to analyze the variables associated with neurosyphilis in Brazilian newborns of pregnant women with syphilis admitted for childbirth. Newborns were submitted to treponemal and non-treponemal tests, cerebrospinal fluid analysis, and long bone radiography. Newborns diagnosed with neurosyphilis and congenital syphilis were defined as cases and controls, respectively. The length of hospitalization and mean cost of neurosyphilis treatment were also evaluated. Twenty-one cases of newborns with neurosyphilis and 42 controls with congenital syphilis were included in the study. Out of 63 pregnant women with syphilis, 95.2% (60/63) received prenatal care, 74.6% (47/63) were diagnosed with syphilis during this period, 31.9% (15/47) underwent treponemic tests, 80.8% (38/47) were treated with penicillin and only 46.8% (22/47) of the partners received the treatment. Clinical complications such as low birth weight were observed in 12.7% (8/63) of the newborns. About 50.8% (32/63) of the newborns were hospitalized due to syphilis complications and each case of neurosyphilis spent at least US$ 881.48 on treatment and hospitalization. The results showed that the prenatal coverage is not sufficient to prevent neurosyphilis. The late diagnosis of syphilis in pregnant women and inadequate follow-up of sexual partners may favor the vertical transmission of T. pallidum in pregnant Brazilian women. Thus, improving the quality of health services is important for a more effective control of neurosyphilis.


Assuntos
Neurossífilis/tratamento farmacológico , Penicilinas/uso terapêutico , Complicações Infecciosas na Gravidez/tratamento farmacológico , Sífilis Congênita/diagnóstico , Sífilis/tratamento farmacológico , Adulto , Brasil/epidemiologia , Estudos de Casos e Controles , Feminino , Humanos , Recém-Nascido , Neurossífilis/diagnóstico , Neurossífilis/epidemiologia , Gravidez , Complicações Infecciosas na Gravidez/diagnóstico , Gestantes , Sífilis/diagnóstico , Sífilis/epidemiologia , Sorodiagnóstico da Sífilis , Sífilis Congênita/epidemiologia
7.
Rio de Janeiro; s.n; ilus; 2020. 169 p. ilus.
Tese em Português | LILACS | ID: biblio-1252412

RESUMO

Tuberculose (TB) é uma doença infectocontagiosa com grande morbiletalidade em todo o mundo. A eficácia do tratamento da TB em crianças e adolescentes pode ser comprometida pela falta de informações sobre a doença, seu tratamento, formas de contágio e, principalmente, sobre a administração correta da medicação. O objetivo primário do estudo foi realizar uma ação educativa sobre TB para crianças e jovens com a forma ativa e latente da doença em tratamento no Centro Municipal de Saúde de Duque de Caxias, assim como para seus cuidadores. Realizamos entre maio e outubro de 2019 um estudo qualiquantitativo, baseado em questionário padronizado sobre conhecimento, atitudes e práticas (CAP) sobre TB, seguido da ação educativa. Para a ação educativa elaboramos 11 telas, para exibição por computador ou tablet, que abordavam aspectos da transmissão, manifestações clínicas, tratamento e prevenção da TB pediátrica. Um total de 58 crianças e adolescentes (63% do sexo feminino, mediana de idade de 10 anos) e 41 cuidadores (todas mulheres, mediana de idade de 36 anos, 75% mães) participaram do estudo. Das 36 cuidadoras que responderam ao questionário CAP, 86% conheciam a TB e apontaram a tosse (97%), febre e emagrecimento (94%) e emagrecimento (92%) como os principais sinais e sintomas da doença. Indagadas sobre o modo de transmissão da TB, 97% disseram que seria através do ar, mas 65% disseram também que poderia se dar por meio de objetos. Noventa e cinco por cento das cuidadoras não sabiam o que era TB latente. Todas as cuidadoras disseram que a cura da TB é possível tomando os remédios e comparecendo às consultas.


Quanto à administração dos medicamentos, 37% das cuidadoras referiram dificuldade em administrar o medicamento e 26% tiveram que quebrar os comprimidos devido à dificuldade da criança em engoli-los. Quando os jovens foram perguntados se conheciam outras pessoas com TB, 81% disseram que sim, sendo que 38% citaram os próprios pais. O diagnóstico da TB causou sentimentos de medo (75%) e tristeza (72%) nas cuidadoras e 57% perceberam mudança de comportamento das pessoas quando souberam da TB nas suas famílias. As variáveis associadas a um maior conhecimento sobre TB entre as cuidadoras foram idade > 35 anos e morar em residências com mais de cinco pessoas. Ao final do encontro foi solicitada a avaliação dos participantes sobre o recurso educativo usado, utilizando-se para isso uma escala de Likert. A ação educativa foi apreciada pelas cuidadoras, porém as crianças foram mais críticas: 13% acharam que o tempo empregado foi longo e 17% consideraram a linguagem utilizada complexa. Nossos resultados mostram que há lacunas de conhecimento a respeito da transmissão e das formas de TB (ativa e latente). A manipulação dos fármacos é frequente e dificulta o correto tratamento das crianças, problema que deve ser reduzido com a disponibilidade das novas formulações. A ação educativa em saúde foi bem avaliada e acreditamos que possa ter contribuído para que os participantes aprimorassem seus conhecimentos sobre a TB, reduzindo o estigma associado à doença e aumentando a chance de um desfecho favorável do tratamento. (AU)


Assuntos
Humanos , Criança , Adolescente , Tuberculose , Criança , Cuidadores , Educação , Prevenção de Doenças
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA